10:00

Olaparib – LYNPARZA® COMPRIMES

7:10

Dr. Carlos Doti Explains How AstraZeneca's LYNPARZA Has Changed Oncology

4:28

FDA clears Lynparza for prostate cancer treatment

6:53

The story of olaparib: a life-saving cancer drug

5:48

SOLO1: 7-Year Follow-up Highlights the Value of Maintenance Olaparib

9:15

FDA Approval of LYNPARZA® in US for HRR gene-mutated mCRPC

34:17

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

3:31

Olaparib